dlvr.it
PTC Therapeutics completes ST-920 gene therapy acquisition - Investing.com
PTC Therapeutics completes ST-920 gene therapy acquisition Investing.com
#pharma is an active hashtag on Bluesky. In the last 30 days, 78 people shared 384 posts with it — around 13 a day. Activity is up 34% versus the previous week, peaking on Aug 24 with 27 posts.
Tags most often used together with #pharma.
dlvr.it
PTC Therapeutics completes ST-920 gene therapy acquisition - Investing.com
PTC Therapeutics completes ST-920 gene therapy acquisition Investing.com
dlvr.it
Ride Therapeutics raises $8M seed for non-viral gene delivery - Dealroom
Ride Therapeutics raises $8M seed for non-viral gene delivery Dealroom
dlvr.it
Beacon’s XLRP gene therapy meets pivotal U.S. endpoint - European Biotechnology Magazine
Beacon’s XLRP gene therapy meets pivotal U.S. endpoint European Biotechnology Magazine
www.cnbc.com
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
www.fiercebiotech.com
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition
Telix has struck a deal to buy ITM Isotope Technologies Munich | Telix has struck a deal to buy ITM Isotope Technologies Munich for $1.65 billion upfront, securing an R&D pipeline led by a rival to No...
dlvr.it
Beacon of hope for XLRP patients on Phase III gene therapy success - Clinical Trials Arena
Beacon of hope for XLRP patients on Phase III gene therapy success Clinical Trials Arena
dlvr.it
Retension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede
Eli Lilly-backed TRex Bio and hypertension-focused Retension Pharmaceuticals are the latest biotechs to set out plans to go public this year.
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.